These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 553130)

  • 41. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 15 (CAS No. 2429-74-5) in F344 Rats (Drinking Water Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Aug; 397():1-245. PubMed ID: 12637962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
    Moser VC; Walls I; Zoetis T
    Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiologic issues in neurotoxicity research.
    Baker EL
    Neurobehav Toxicol Teratol; 1985; 7(4):293-7. PubMed ID: 4058642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing.
    Weingand K; Brown G; Hall R; Davies D; Gossett K; Neptun D; Waner T; Matsuzawa T; Salemink P; Froelke W; Provost JP; Dal Negro G; Batchelor J; Nomura M; Groetsch H; Boink A; Kimball J; Woodman D; York M; Fabianson-Johnson E; Lupart M; Melloni E
    Fundam Appl Toxicol; 1996 Feb; 29(2):198-201. PubMed ID: 8742316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current problems in the choice of animals for toxicity testing.
    Stevenson DE
    J Toxicol Environ Health; 1979 Jan; 5(1):9-15. PubMed ID: 423310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methodological aspects of acute toxicity testing particularly LD50 determinations present use in development of new drugs.
    Fowler JS; Rutty DA
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():20-30. PubMed ID: 6880781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicological procedures for assessing the carcinogenic potential of agricultural chemicals.
    Krewski D; Clayson D; Collins B; Munro IC
    Basic Life Sci; 1982; 21():461-97. PubMed ID: 6756380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The LD50 test.
    Paget E
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():6-19. PubMed ID: 6880787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multistrain experiments for screening toxic substances.
    Felton RP; Gaylor DW
    J Toxicol Environ Health; 1989; 26(4):399-411. PubMed ID: 2709435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A critical review of the optimum duration of chronic rodent testing for the determination of non-tumourigenic toxic potential: a report by the BTS Working Party on Duration of Toxicity Testing.
    Betton G; Cockburn A; Harpur E; Hopkins J; Illing P; Lumley C; Connors T
    Hum Exp Toxicol; 1994 Apr; 13(4):221-32. PubMed ID: 8204306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shortcomings of LD50-values and acute toxicity testing in animals.
    Rowan A
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():52-64. PubMed ID: 6880786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diffusion proportioning of given concentrations of toxic substances in the air of test chambers].
    Dmitriev MT; Mishchikhin VA
    Gig Sanit; 1979 Mar; (3):41-6. PubMed ID: 422042
    [No Abstract]   [Full Text] [Related]  

  • 54. Avoiding megamouse experiments.
    Simon W
    J Toxicol Environ Health; 1980 Jul; 6(4):907-10. PubMed ID: 7420490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic considerations in the design and interpretation of developmental toxicity studies.
    Nau H
    Fundam Appl Toxicol; 1991 Feb; 16(2):219-21. PubMed ID: 2055351
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimation of toxic hazard--a decision tree approach.
    Cramer GM; Ford RA; Hall RL
    Food Cosmet Toxicol; 1978 Jun; 16(3):255-76. PubMed ID: 357272
    [No Abstract]   [Full Text] [Related]  

  • 57. A new approach to practical acute toxicity testing.
    Lorke D
    Arch Toxicol; 1983 Dec; 54(4):275-87. PubMed ID: 6667118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shortcomings of alternative techniques for the assessment of acute toxicity.
    Rowan A
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():190-200. PubMed ID: 6880780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceedings: What is the value of the basic control?
    Lorke D
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R59. PubMed ID: 4276606
    [No Abstract]   [Full Text] [Related]  

  • 60. Mathematical processes in the evaluation of the dangerous nature of chemicals.
    Hahn E; Siebert G
    Regul Toxicol Pharmacol; 1982 Dec; 2(4):345-61. PubMed ID: 7185101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.